Epsilogen Ltd

Description: Pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; anti-cancer drugs; anti-cancer preparations; anti-cancer preparations of plant origin; anti-cancer preparations of chemical origin; compounds for treating cancer; tumor suppressing agents; immunostimulants; medicine for the treatment of cancer; diagnostic reagents for medical laboratory use | Development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; research and development of pharmaceuticals in the fields of oncology, immunology and immuno-oncology; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies; research and development in the field of recombinant proteins and antibodies for therapeutic and prophylactic use; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new therapeutic proteins and antibodies; development of pharmaceuticals, pharmaceutical ingredients, and antibodies; scientific study and research in the field of developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical services, namely, developing tumor targeting platform technologies; scientific research in the nature of scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the fields of oncology, immunology and immuno-oncology; pharmaceutical product development and evaluation services; pharmaceutical research and development; technical research in the field of pharmaceutical studies; conducting early evaluations in the field of new pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services in the fields of biotechnology and pharmaceutical research; consulting services for others in the field of design, planning, and implementation of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials | Medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of cancerous diseases; pharmaceutical advisory services; medical laboratory analysis services relating to the treatment of persons; medical laboratory analysis services relating to the diagnosis and treatment of cancerous diseases; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncology | Licensing of intellectual property rights; licensing of industrial property rights

Description: Pharmaceutical drugs for suppressing tumors; pharmaceutical drugs for treating malignant tumors; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; anti-cancer drugs; anti-cancer preparations; anti-cancer preparations of plant origin; anti-cancer preparations of chemical origin; compounds for treating cancer; tumor suppressing agents; immunostimulants; medicine for suppressing tumors; medicine for treating malignant tumors; medicine for the treatment of cancer; diagnostic reagents for medical laboratory use | Scientific and technological services, namely, scientific research in the field of pharmaceutical research and development and research and design relating thereto; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; clinical research in the field of cancer treatment; clinical trials for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; scientific research for medical purposes in the area of cancerous diseases; research and development services of technology in the fields of oncology, immunology and immuno-oncology | Medical treatment services of cancerous diseases; medical screening of cancerous diseases; medical diagnostic monitoring, testing, and analysis services; medical services, namely, diagnosis and treatment of cancerous diseases; pharmaceutical services, namely, dispensing pharmaceuticals; pharmaceutical services, namely, pharmaceutical consultation; pharmaceutical services, namely, pharmaceutical compounding services; pharmaceutical advisory services; laboratory analysis services relating to the treatment of persons by medical laboratories; laboratory analysis services relating to the diagnosis and treatment of cancerous diseases by medical laboratories; providing cancer screening services; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis by medical laboratories; medical services in the field of oncology, immunology and immuno-oncology; providing advice relating to oncology, immunology and immuno-oncology; providing on-line information relating to oncology, immunology and immuno-oncology